Skip to main content
Clinical Trials/JPRN-UMIN000034089
JPRN-UMIN000034089
Not yet recruiting
未知

Development of prediction model for the efficacy of anti-PD-1 antibody on malignant pleural mesothelioma - Prediction model in MPM

Hyogo college of medicine0 sites50 target enrollmentOctober 15, 2018

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
Hyogo college of medicine
Enrollment
50
Status
Not yet recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
October 15, 2018
End Date
TBD
Last Updated
2 years ago
Study Type
Observational
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • 1 Patients receiving pervious systemic chemotherapies (two or more regimens), including platinum agent and pemetrexede combination therapy. 2 Patients with ECOG PS 2 or more 3 Patients receiving steriod therapy (10mg per day or more) 4 Patients receiving antibiotics between 4 weeks before and after the nivolumab therapy 5 Patients who are deemed inappropriate as study participants by investigators or medical doctors.

Outcomes

Primary Outcomes

Not specified

Similar Trials